Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. to Present New Clinical Data at Heart Rhythm 2021 Annual Convention
June 15, 2021 08:30 ET | BioSig Technologies, Inc.
Westport, CT, June 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event
June 07, 2021 08:30 ET | BioSig Technologies, Inc.
Westport, CT, June 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference
May 28, 2021 10:30 ET | BioSig Technologies, Inc.
Westport, CT, May 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
May 21, 2021 09:15 ET | BioSig Technologies, Inc.
Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
May 04, 2021 09:15 ET | BioSig Technologies, Inc.
Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) -- The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians...
Bio-Sig-Logo-horiz.jpg
BioSig Technologies, Inc. Invited to Present at Wall Street Conference
May 03, 2021 12:00 ET | BioSig Technologies, Inc.
Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
April 27, 2021 09:30 ET | BioSig Technologies, Inc.
Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) -- The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatmentsNew installation...
Bio-Sig-Logo-horiz.jpg
BioSig Expands Commercial Team in Two Strategic Regions
April 15, 2021 11:45 ET | BioSig Technologies, Inc.
Westport, CT, April 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
April 14, 2021 09:29 ET | BioSig Technologies, Inc.
Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) -- The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular...
Bio-Sig-Logo-horiz.jpg
BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
April 13, 2021 09:32 ET | BioSig Technologies, Inc.
Westport, CT, April 13, 2021 (GLOBE NEWSWIRE) -- 51 patients undergoing elective cardiac ablation treatments were enrolled in the trial at Mayo Clinic, Massachusetts General Hospital, and St....